CRISPR Therapeutics AG (CRSP)
56.76
-0.10
(-0.18%)
USD |
NASDAQ |
Apr 15, 16:00
56.98
+0.22
(+0.39%)
After-Hours: 06:11
CRISPR Therapeutics Market Cap : 5.448B for April 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 112.21B |
| Novartis AG | 290.19B |
| EvoNext Holdings SA | 8.149M |
| Kuros Biosciences Ltd. | 1.089B |
| Basilea Pharmaceutica AG | 853.56M |
Market Cap Related Metrics
| PS Ratio | 1453.70 |
| PEG Ratio | -0.1762 |
| Price to Book Value | 2.835 |
| Price | 56.76 |
| Earnings Yield | -11.48% |
| PEGY Ratio | -0.1762 |